Cigna Corp (CI)
Cigna Corp (CI) carries a ŷRobot AI score of 57 out of 100. The model's fair value estimate is $288.00, 4.7% below the last close of $302.30. The chart signal reads Sell.
| Metric | CI |
|---|---|
| AI score | 57 / 100 |
| Chart signal | Sell |
| Fair value estimate | $288.00 |
| Upside to fair value | -4.7% |
| Previous close | $302.30 |
| P/E | 11.24 |
| Price / sales | 0.25 |
| Market cap | $78.96B |
| EPS | 24.19 |
| Revenue growth | 14.9% |
| 1-year price change | 4.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about CI
Is CI overvalued or undervalued right now?
As of Oct 17, 2026, ŷRobot's fair-value model estimates Cigna Corp (CI) at $288.00 against a last close of $302.30, implying 4.7% downside to the model's estimate.
Is CI's chart signal bullish or bearish?
The chart-signal model classifies CI as Neutral as of Oct 17, 2026, with a signal score of -0.11 on a -1 to 1 scale.
What is CI's ŷRobot AI score?
CI scores 57 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 17, 2026.
Is CI stock expensive on P/E and P/S?
CI trades at 11.2 times earnings and 0.3 times sales as of Oct 17, 2026.
What does CI's seasonal forecast show?
ŷRobot's seasonal forecast curve for CI reads +2.5% at 30 days, +6.2% at 90 days, and +4.1% at one year as of Oct 17, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CI growing?
Cigna Corp's revenue growth is +14.9% and free-cash-flow growth is -0.6% on the latest reported figures.
CI chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.